Recently, it has been hypothesized that inhibition of dopaminergic signaling through PDE10A could represent a novel non-receptor-based mechanism for the reduction of psychosis and related cognitive dysfunction in schizophrenia [40,41,71]. The gene discussed is PDE10A; the disease is schizophrenia.